Annual EBIT
$27.60 M
+$73.95 M+159.56%
May 26, 2024
Summary
- As of February 7, 2025, LFCR annual earnings before interest & taxes is $27.60 million, with the most recent change of +$73.95 million (+159.56%) on May 26, 2024.
- During the last 3 years, LFCR annual EBIT has risen by +$48.46 million (+232.37%).
- LFCR annual EBIT is now -19.46% below its all-time high of $34.27 million, reached on May 1, 2013.
Performance
LFCR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.06 M
+$9.82 M+90.24%
November 24, 2024
Summary
- As of February 7, 2025, LFCR quarterly earnings before interest & taxes is -$1.06 million, with the most recent change of +$9.82 million (+90.24%) on November 24, 2024.
- Over the past year, LFCR quarterly EBIT has dropped by -$20.35 million (-105.51%).
- LFCR quarterly EBIT is now -104.05% below its all-time high of $26.28 million, reached on February 1, 2007.
Performance
LFCR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$5.99 M
-$19.31 M-76.33%
November 24, 2024
Summary
- As of February 7, 2025, LFCR TTM earnings before interest & taxes is $5.99 million, with the most recent change of -$19.31 million (-76.33%) on November 24, 2024.
- Over the past year, LFCR TTM EBIT has increased by +$7.89 million (+414.83%).
- LFCR TTM EBIT is now -84.15% below its all-time high of $37.78 million, reached on November 1, 2007.
Performance
LFCR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
LFCR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +159.6% | -105.5% | +414.8% |
| 3 y3 years | +232.4% | -105.5% | +414.8% |
| 5 y5 years | +211.2% | +81.5% | +127.8% |
LFCR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +159.6% | -105.5% | +96.6% | -78.3% | +111.6% |
| 5 y | 5-year | at high | +159.6% | -105.5% | +96.6% | -78.3% | +111.6% |
| alltime | all time | -19.5% | +159.6% | -104.0% | +96.8% | -84.2% | +111.6% |
Lifecore Biomedical EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2024 | - | -$1.06 M(-90.2%) | $5.99 M(-76.3%) |
| Aug 2024 | - | -$10.89 M(+704.7%) | $25.30 M(-8.3%) |
| May 2024 | $27.60 M(-159.6%) | -$1.35 M(-107.0%) | $27.60 M(-1551.3%) |
| Feb 2024 | - | $19.29 M(+5.7%) | -$1.90 M(-93.1%) |
| Nov 2023 | - | $18.25 M(-312.6%) | -$27.62 M(-46.3%) |
| Aug 2023 | - | -$8.58 M(-72.2%) | -$51.46 M(+11.0%) |
| May 2023 | -$46.35 M(+788.4%) | -$30.86 M(+380.1%) | -$46.35 M(+163.2%) |
| Feb 2023 | - | -$6.43 M(+15.0%) | -$17.61 M(+27.6%) |
| Nov 2022 | - | -$5.59 M(+61.0%) | -$13.80 M(+247.3%) |
| Aug 2022 | - | -$3.47 M(+63.8%) | -$3.97 M(+27.9%) |
| May 2022 | -$5.22 M(-75.0%) | -$2.12 M(-19.1%) | -$3.11 M(-83.3%) |
| Feb 2022 | - | -$2.62 M(-161.8%) | -$18.64 M(+27.6%) |
| Nov 2021 | - | $4.24 M(-262.6%) | -$14.60 M(-54.1%) |
| Aug 2021 | - | -$2.61 M(-85.2%) | -$31.80 M(-23.2%) |
| May 2021 | -$20.85 M(-19.8%) | - | - |
| May 2021 | - | -$17.65 M(-1346.4%) | -$41.40 M(+63.5%) |
| Feb 2021 | - | $1.42 M(-110.9%) | -$25.32 M(-38.8%) |
| Nov 2020 | - | -$12.96 M(+6.2%) | -$41.35 M(+21.2%) |
| Aug 2020 | - | -$12.20 M(+676.1%) | -$34.13 M(+31.3%) |
| May 2020 | -$26.00 M(-393.1%) | -$1.57 M(-89.2%) | -$26.00 M(+20.9%) |
| Feb 2020 | - | -$14.62 M(+154.8%) | -$21.50 M(+572.6%) |
| Nov 2019 | - | -$5.74 M(+40.8%) | -$3.20 M(-189.0%) |
| Aug 2019 | - | -$4.07 M(-239.3%) | $3.59 M(-59.5%) |
| May 2019 | $8.87 M(-51.7%) | $2.92 M(-20.7%) | $8.87 M(-41.6%) |
| Feb 2019 | - | $3.69 M(+249.7%) | $15.18 M(-1.9%) |
| Nov 2018 | - | $1.05 M(-12.2%) | $15.48 M(-0.0%) |
| Aug 2018 | - | $1.20 M(-87.0%) | $15.48 M(-15.6%) |
| May 2018 | $18.35 M(+14.7%) | $9.23 M(+131.7%) | $18.35 M(+61.9%) |
| Feb 2018 | - | $3.98 M(+276.3%) | $11.33 M(-11.4%) |
| Nov 2017 | - | $1.06 M(-74.0%) | $12.80 M(-9.8%) |
| Aug 2017 | - | $4.07 M(+83.5%) | $14.18 M(-11.4%) |
| May 2017 | $16.00 M(-190.4%) | $2.22 M(-59.3%) | $16.00 M(-22.5%) |
| Feb 2017 | - | $5.45 M(+122.7%) | $20.65 M(-214.8%) |
| Nov 2016 | - | $2.45 M(-58.4%) | -$17.99 M(+5.8%) |
| Aug 2016 | - | $5.89 M(-14.3%) | -$17.00 M(-4.0%) |
| May 2016 | -$17.71 M(-176.0%) | $6.87 M(-120.7%) | -$17.71 M(+1.0%) |
| Feb 2016 | - | -$33.19 M(-1066.0%) | -$17.52 M(-178.6%) |
| Nov 2015 | - | $3.44 M(-33.7%) | $22.31 M(-8.5%) |
| Aug 2015 | - | $5.18 M(-26.5%) | $24.37 M(+4.6%) |
| May 2015 | $23.30 M(-26.2%) | $7.05 M(+6.3%) | $23.30 M(-2.2%) |
| Feb 2015 | - | $6.64 M(+20.6%) | $23.81 M(-13.9%) |
| Nov 2014 | - | $5.50 M(+34.0%) | $27.67 M(-1.1%) |
| Aug 2014 | - | $4.11 M(-45.7%) | $27.97 M(-11.4%) |
| May 2014 | $31.57 M(-7.9%) | $7.56 M(-27.9%) | $31.57 M(+4.2%) |
| Feb 2014 | - | $10.49 M(+80.8%) | $30.29 M(+8.8%) |
| Nov 2013 | - | $5.80 M(-24.8%) | $27.83 M(-19.1%) |
| Aug 2013 | - | $7.72 M(+22.9%) | $34.42 M(+0.4%) |
| May 2013 | $34.27 M(+61.6%) | $6.28 M(-21.8%) | $34.27 M(+5.7%) |
| Feb 2013 | - | $8.03 M(-35.2%) | $32.43 M(+0.5%) |
| Nov 2012 | - | $12.39 M(+63.7%) | $32.28 M(+26.4%) |
| Aug 2012 | - | $7.57 M(+70.6%) | $25.54 M(+20.4%) |
| May 2012 | $21.21 M(+129.0%) | $4.44 M(-43.7%) | $21.21 M(+45.4%) |
| Feb 2012 | - | $7.89 M(+39.6%) | $14.59 M(+38.0%) |
| Nov 2011 | - | $5.65 M(+74.4%) | $10.57 M(+24.0%) |
| Aug 2011 | - | $3.24 M(-248.0%) | $8.52 M(-8.0%) |
| May 2011 | $9.26 M(+5.1%) | -$2.19 M(-156.6%) | $9.26 M(-17.1%) |
| Feb 2011 | - | $3.87 M(+7.4%) | $11.18 M(+9.7%) |
| Nov 2010 | - | $3.60 M(-9.6%) | $10.19 M(+11.4%) |
| Aug 2010 | - | $3.98 M(-1542.8%) | $9.15 M(+3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| May 2010 | $8.82 M(-36.6%) | -$276.00 K(-109.6%) | $8.82 M(-30.1%) |
| Feb 2010 | - | $2.88 M(+12.7%) | $12.62 M(+0.9%) |
| Nov 2009 | - | $2.56 M(-29.9%) | $12.50 M(+2.6%) |
| Aug 2009 | - | $3.65 M(+3.5%) | $12.18 M(-7.0%) |
| May 2009 | $13.90 M(-8.4%) | $3.53 M(+27.4%) | $13.09 M(+22.9%) |
| Feb 2009 | - | $2.77 M(+23.5%) | $10.66 M(-20.4%) |
| Nov 2008 | - | $2.24 M(-50.8%) | $13.38 M(-10.6%) |
| Aug 2008 | - | $4.56 M(+318.3%) | $14.97 M(+6.8%) |
| May 2008 | $15.18 M(-50.0%) | $1.09 M(-80.1%) | $14.02 M(-17.5%) |
| Feb 2008 | - | $5.49 M(+43.4%) | $17.00 M(-55.0%) |
| Nov 2007 | - | $3.83 M(+6.2%) | $37.78 M(+10.8%) |
| Aug 2007 | - | $3.61 M(-11.4%) | $34.10 M(+12.3%) |
| May 2007 | $30.36 M(+236.5%) | $4.07 M(-84.5%) | $30.36 M(-8.1%) |
| Feb 2007 | - | $26.28 M(>+9900.0%) | $33.03 M(+221.5%) |
| Nov 2006 | - | $147.00 K(-213.1%) | $10.28 M(+11.2%) |
| Aug 2006 | - | -$130.00 K(-101.9%) | $9.24 M(+2.4%) |
| May 2006 | $9.02 M(+50.0%) | $6.74 M(+91.4%) | $9.02 M(+30.0%) |
| Feb 2006 | - | $3.52 M(-497.7%) | $6.94 M(+18.5%) |
| Nov 2005 | - | -$885.00 K(+152.1%) | $5.86 M(-4.1%) |
| Aug 2005 | - | -$351.00 K(-107.5%) | $6.11 M(+1.5%) |
| May 2005 | $6.02 M(+48.4%) | $4.66 M(+91.2%) | $6.02 M(+0.4%) |
| Feb 2005 | - | $2.44 M(-483.5%) | $5.99 M(+33.4%) |
| Nov 2004 | - | -$635.00 K(+44.6%) | $4.49 M(+14.0%) |
| Aug 2004 | - | -$439.00 K(-109.5%) | $3.94 M(-2.9%) |
| May 2004 | $4.05 M(+75.8%) | $4.63 M(+394.7%) | $4.06 M(-5.9%) |
| Feb 2004 | - | $936.00 K(-178.8%) | $4.31 M(+186.5%) |
| Nov 2003 | - | -$1.19 M(+268.9%) | $1.50 M(-13.4%) |
| Aug 2003 | - | -$322.00 K(-106.6%) | $1.74 M(+20.3%) |
| May 2003 | $2.31 M(+83.3%) | - | - |
| Apr 2003 | - | $4.89 M(-361.1%) | $1.44 M(-37.6%) |
| Jan 2003 | - | -$1.87 M(+95.7%) | $2.31 M(+84.0%) |
| Oct 2002 | $1.26 M(-147.5%) | -$956.00 K(+55.4%) | $1.26 M(+464.1%) |
| Jul 2002 | - | -$615.00 K(-110.7%) | $223.00 K(>+9900.0%) |
| Apr 2002 | - | $5.76 M(-296.6%) | $1000.00(-100.0%) |
| Jan 2002 | - | -$2.93 M(+47.1%) | -$2.14 M(-19.6%) |
| Oct 2001 | -$2.65 M(+220.8%) | -$1.99 M(+137.9%) | -$2.66 M(+19.0%) |
| Jul 2001 | - | -$837.00 K(-123.1%) | -$2.24 M(+53.7%) |
| Apr 2001 | - | $3.62 M(-204.8%) | -$1.46 M(-20.4%) |
| Jan 2001 | - | -$3.45 M(+120.4%) | -$1.83 M(+108.3%) |
| Oct 2000 | -$825.00 K(-78.0%) | -$1.57 M(+2747.3%) | -$878.00 K(-67.0%) |
| Jul 2000 | - | -$55.00 K(-101.7%) | -$2.66 M(-43.5%) |
| Apr 2000 | - | $3.24 M(-229.7%) | -$4.70 M(+1.8%) |
| Jan 2000 | - | -$2.50 M(-25.3%) | -$4.62 M(+20.9%) |
| Oct 1999 | -$3.75 M(+13.5%) | -$3.35 M(+59.3%) | -$3.82 M(+24.3%) |
| Jul 1999 | - | -$2.10 M(-163.1%) | -$3.07 M(+19.4%) |
| Apr 1999 | - | $3.33 M(-295.6%) | -$2.57 M(-22.0%) |
| Jan 1999 | - | -$1.70 M(-34.6%) | -$3.30 M(0.0%) |
| Oct 1998 | -$3.30 M(-63.3%) | -$2.60 M(+62.5%) | -$3.30 M(+120.0%) |
| Jul 1998 | - | -$1.60 M(-161.5%) | -$1.50 M(+15.4%) |
| Apr 1998 | - | $2.60 M(-252.9%) | -$1.30 M(-84.3%) |
| Jan 1998 | - | -$1.70 M(+112.5%) | -$8.30 M(-2.4%) |
| Oct 1997 | -$9.00 M(+109.3%) | -$800.00 K(-42.9%) | -$8.50 M(0.0%) |
| Jul 1997 | - | -$1.40 M(-68.2%) | -$8.50 M(-1.2%) |
| Apr 1997 | - | -$4.40 M(+131.6%) | -$8.60 M(+75.5%) |
| Jan 1997 | - | -$1.90 M(+137.5%) | -$4.90 M(+88.5%) |
| Oct 1996 | -$4.30 M | -$800.00 K(-46.7%) | -$2.60 M(+44.4%) |
| Jul 1996 | - | -$1.50 M(+114.3%) | -$1.80 M(+500.0%) |
| Apr 1996 | - | -$700.00 K(-275.0%) | -$300.00 K(-175.0%) |
| Jan 1996 | - | $400.00 K | $400.00 K |
FAQ
- What is Lifecore Biomedical annual earnings before interest & taxes?
- What is the all time high annual EBIT for Lifecore Biomedical?
- What is Lifecore Biomedical annual EBIT year-on-year change?
- What is Lifecore Biomedical quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Lifecore Biomedical?
- What is Lifecore Biomedical quarterly EBIT year-on-year change?
- What is Lifecore Biomedical TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Lifecore Biomedical?
- What is Lifecore Biomedical TTM EBIT year-on-year change?
What is Lifecore Biomedical annual earnings before interest & taxes?
The current annual EBIT of LFCR is $27.60 M
What is the all time high annual EBIT for Lifecore Biomedical?
Lifecore Biomedical all-time high annual earnings before interest & taxes is $34.27 M
What is Lifecore Biomedical annual EBIT year-on-year change?
Over the past year, LFCR annual earnings before interest & taxes has changed by +$73.95 M (+159.56%)
What is Lifecore Biomedical quarterly earnings before interest & taxes?
The current quarterly EBIT of LFCR is -$1.06 M
What is the all time high quarterly EBIT for Lifecore Biomedical?
Lifecore Biomedical all-time high quarterly earnings before interest & taxes is $26.28 M
What is Lifecore Biomedical quarterly EBIT year-on-year change?
Over the past year, LFCR quarterly earnings before interest & taxes has changed by -$20.35 M (-105.51%)
What is Lifecore Biomedical TTM earnings before interest & taxes?
The current TTM EBIT of LFCR is $5.99 M
What is the all time high TTM EBIT for Lifecore Biomedical?
Lifecore Biomedical all-time high TTM earnings before interest & taxes is $37.78 M
What is Lifecore Biomedical TTM EBIT year-on-year change?
Over the past year, LFCR TTM earnings before interest & taxes has changed by +$7.89 M (+414.83%)